Oral Octreotide Absorption in Human Subjects: Comparable Pharmacokinetics to Parenteral Octreotide and Effective Growth Hormone Suppression-Reference-Cited by-同舟云学术

Oral Octreotide Absorption in Human Subjects: Comparable Pharmacokinetics to Parenteral Octreotide and Effective Growth Hormone Suppression

Published:2012-07 Issue:7 Volume:97 Page:2362-2369
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:The Journal of Clinical Endocrinology & Metabolism

Author:

Tuvia S.,Atsmon J.,Teichman S. L.,Katz S.,Salama P.,Pelled D.,Landau I.,Karmeli I.,Bidlingmaier M.,Strasburger C. J.,Kleinberg D. L.,Melmed S.,Mamluk R.

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LabrafacTM MC60 is an efficacious intestinal permeation enhancer for macromolecules: Comparisons with Labrasol® ALF in ex vivo and in vivo rat studies;International Journal of Pharmaceutics;2024-08

2. Treatment of acromegaly with oral octreotide;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

3. Targeting Nrf2 by bioactive peptides alleviate inflammation: expanding the role of gut microbiota and metabolites;Critical Reviews in Food Science and Nutrition;2024-06-17

4. Oral octreotide capsules for acromegaly treatment: application of clinical trial insights to real-world use;Expert Review of Endocrinology & Metabolism;2024-06-06

5. Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine;The Journal of Clinical Endocrinology & Metabolism;2024-06-03